Dr. Michael Hermelin, M.D.
What this data tells you about Dr. Hermelin
Dr. Michael Hermelin is an internal medicine specialist in Cypress, TX, with 10 years of NPI registration. Based on federal Medicare data, Dr. Hermelin performed 2,841 Medicare services across 1,690 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hermelin received a total of $7,451 from 41 pharmaceutical and/or device companies across 238 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hermelin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month | 496 | $50 | $100 |
| Hospital follow-up visit, high complexity | 371 | $96 | $299 |
| EKG interpretation and report | 361 | $7 | $20 |
| Echocardiogram, transthoracic | 232 | $138 | $495 |
| Office visit, established patient (30-39 min) | 192 | $100 | $321 |
| Ultrasound of both sides of head and neck blood flow | 187 | $145 | $485 |
| Chronic care management, additional 20 min/month | 168 | $38 | $75 |
| Regadenoson injection (Lexiscan) for heart stress test | 168 | $40 | $191 |
| Electrocardiogram (EKG), 12-lead | 156 | $11 | $36 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 78 | $49 | $100 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 61 | $52 | $177 |
| Initial hospital admission, high complexity | 39 | $138 | $436 |
| Ultrasound of leg arteries or artery grafts | 38 | $194 | $606 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 29 | $355 | $1,103 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 29 | $121 | $456 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 29 | $701 | $1,572 |
| New patient office visit (45-59 min) | 28 | $119 | $419 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 24 | $209 | $663 |
| Office visit, established patient, complex (40-54 min) | 24 | $135 | $450 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 23 | $138 | $476 |
| Office visit, established patient (20-29 min) | 19 | $73 | $227 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 18 | $1,936 | $3,000 |
| Nuclear medicine study of heart muscle blood flow by pet | 18 | $146 | $1,500 |
| Hospital follow-up visit, moderate complexity | 18 | $64 | $199 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 18 | $651 | $2,400 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 17 | $10 | $35 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hermelin is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with low-engagement industry engagement in the top 11% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hermelin experienced with chronic care management, first 20 min/month?
Does Dr. Hermelin receive payments from pharmaceutical companies?
How do Dr. Hermelin's costs compare to other internal medicine physicians in Cypress?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology